Enhanced proliferation and increased IFN-γ production in T cells by signal transduced through TNF-related apoptosis-inducing ligand

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1347-1352

  Chou, A H ^a   Tsai, H F ^a   Lin, L L ^a   Hsieh, S L ^a   Hsu, P I ^a   Hsu, P N ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CONTACT; CELL ISOLATION; CELL PROLIFERATION; ENZYME INHIBITION; IMMUNOBLOTTING; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0035422734     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1347     Document Type: Article

References (31)

1. Tumor necrosis factor receptor superfamily members and their ligands
2. Activation-induced death of mature T cells in the regulation of immune responses
3. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
4. Apoptosis by death factor
5. CD95 (APO-1/Fas)-mediated apoptosis: Live and let die
6. Identification and characterization of a new member of the TNF family that induces apoptosis
7. An antagonist decoy receptor and a death domain-containing receptor for TRAlL
8. The receptor for the cytotoxic ligand TRAIL
9. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
10. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
11. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
12. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
13. A novel receptor for Apo2L/TRAIL contains a truncated death domain
14. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
15. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
16. + T lymphocytes
17. CD40 ligand-transduced co-stimulation of T cells in the development of helper function
18. + T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
19. Reverse signaling via CD30 ligand
20. Aberrant expression and reverse signaling of CD70 on malignant B cells
21. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand
22. + T cells
23. CD137 induces proliferation and endomitosis in monocytes
24. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells
25. Enhanced secretion of IFN-γ by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine
26. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor
27. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells
28. Generation of memory B cells and plasma cells in vitro
29. A casein kinase I motif present in the cytoplasmic domain of members of the tumor necrosis factor ligand family is implicated in "reverse signaling"
30. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression
31. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis